【美股财报】Editas Medicine Inc 2024年度报告.pdf

Medicine shortages: EFPIA proposal for action

3D MEDICINES二零二三年中期报告

3D MEDICINES-B二零二二年年报

Harnessing the Benefits of Externally Controlled Clinical Trials (ECTs) to Accelerate Development of Better Medicines

Annex 1 Socio-Economic Analysis Of the potential restriction of the perand polyfluoroalkyl substances (PFAS) used in the production, packaging and delivery of human medicinal products

Blueprint Medicines Corp 2024年度报告

Disc Medicine Inc美股招股说明书(2025-01-23版)

Disc Medicine Inc美股招股说明书(2025-01-21版)

How Off-Label Use of Medicines Drives Health-Care Use and Disability

Clearmind Medicine Inc 2025年年度报告和过渡报告